Governance Changes

BridgeBio Pharma, Inc.: Amendment to Certificate of Incorporation to include an officer exculpation provision limiting liability of certain officers as permitted by Delaware law (effective 2025-06-23).

“an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time (the “Certificate of Incorporation”) to limit the liability of certain officers of the Company as permitted under current Delaware law (the “Officer Exculpation Amendment”).”

Datacentrex, Inc.: Filed Certificate of Designation for Series C Convertible Preferred Stock, designating 200,000 shares with stated value of $60.00 and voting on as-converted basis (effective 2025-06-17).

“On June 17, 2025, the Company filed with the Nevada Secretary of State a Certificate of Designation, Preferences, Rights and Limitations of Series C Convertible Preferred Stock (the “COD”) designating 200,000 shares of Series C, par value $0.001.”

Sidus Space Inc.: Changed quorum requirement for stockholder meetings to one-third of outstanding shares (effective 2025-06-20).

“On June 20, 2025, the Board of Directors of Sidus Space, Inc. (the “Company”) approved an amendment of the Company’s Bylaws (the “Bylaws”) to change the quorum for stockholder meetings to equal one-third (33.33%) of the shares issued and outstanding and entitled to vote on the matters at the meeting.”

Amrize Ltd: Adopted a Code of Business Conduct effective upon consummation of the spin-off.

“the Company Board adopted a Code of Business Conduct effective as of the consummation of the Spin-off.”

Amrize Ltd: Adopted new organizational regulations effective upon consummation of the spin-off.

“Organizational Regulations Effective as of the consummation of the Spin-off, the Company adopted new organizational regulations (the “Organizational Regulations”).”

Amrize Ltd: Adopted new articles of association effective upon consummation of the spin-off.

“New Articles of Association Effective as of the consummation of the Spin-off, the Company adopted new articles of association (the “New Articles”).”

PHX MINERALS INC.: Bylaws amended and restated in entirety to become the bylaws of Purchaser in effect immediately prior to the effective time of the Merger.

“and the bylaws of the Company were amended and restated in their entirety as the bylaws of Purchaser in effect immediately prior to the effective time of the Merger.”

PHX MINERALS INC.: Certificate of incorporation amended and restated in entirety pursuant to Merger Agreement.

“Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, the certificate of incorporation of the Company was amended and restated to read in its entirety as the certificate of incorporation attached as Exhibit B to the Merger Agreement”

SANMINA CORP: Reduced ownership threshold to call a special meeting from 50% to 25% voting power, added a one-year continuous holding period requirement, and clarified related procedural mechanics. Also includes technical and clarifying changes (effective 2025-06-19).

“Effective June 19, 2025, the board of directors (the “Board”) of Sanmina Corporation, a Delaware corporation (the “Company”), approved and adopted an amendment and restatement of the Company’s Amended and Restated Bylaws (as amended, the “Bylaws”), which became effective immediately. The amendments effected by the Bylaws: · reduce the ownership threshold necessary to call a special meeting of the stockholders from not less than fifty percent of the voting power of the outstanding shares of capital stock of the Company to not less than twenty-five percent of the voting power of the outstanding shares of capital stock of the Company; · establish a one-year continuous holding period required to call a special meeting of the stockholders; and · clarify and update related procedural mechanics.”

SEAFARER EXPLORATION CORP: Increased authorized common shares from 9,900,000,000 to 17,000,000,000 (effective 2025-06-16).

“the Board of Directors, acting as shareholders of the Preferred Shares and pursuant to their own resolution, voted to increase the authorized shares of the Corporation from 9,900,000,000 common shares to 17,000,000,000 common shares.”

BJ's Wholesale Club Holdings, Inc.: Approved and effected an officer exculpation amendment to the second amended and restated certificate of incorporation to permit exculpation of officers as permitted by Delaware law (effective 2025-06-20).

“On June 20, 2025, the company filed a certificate of amendment to the charter (the “certificate of amendment”) with the Secretary of State of the State of Delaware to effect the officer exculpation amendment.”

Cidara Therapeutics, Inc.: Increased authorized shares of common stock from 50,000,000 to 100,000,000 (effective 2025-06-18).

“The increase in the authorized number of shares of Common Stock was effected pursuant to a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) filed with the Secretary of State of the State of Delaware on June 18, 2025 and was effective as of such date.”

CaliberCos Inc.: Amended quorum requirement for shareholder meetings from a majority of shares to 33.3% of outstanding shares entitled to vote (effective 2025-06-16).

“On June 16, 2025, the Board of Directors of CaliberCos Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws (the “Bylaws”) and adopted an amendment to the quorum requirement contained in Section 2.07 of the Bylaws (the “Amendment”) to provide that the holders of thirty-three and one third percent (33.3%) of the outstanding shares of stock of the Company entitled to vote at a shareholders meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business.”

APPlife Digital Solutions Inc: Amended Articles of Incorporation and filed certificates of designation creating Series A, Series B, Series C and Series D Preferred Stock (effective 2025-05-29).

“On May 29, 2025, in conjunction with the closing of the Agreement as described above and as previously disclosed in the Information Statement on Schedule 14C filed with the Securities and Exchange Commission on April 28, 2025, the Company amended its Articles of Incorporation and filed certificates of designation, designating the rights and preferences of the newly created Series A, Series B, Series C and Series D Preferred Stock.”

Unicycive Therapeutics, Inc.: Filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of Common Stock (effective 2025-06-18).

“On June 18, 2025, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware to effectuate the Reverse Stock Split.”

Bakkt, Inc.: Amendment to increase authorized shares of Class A Common Stock from 30,000,000 to 60,000,000 and total Common Stock from 40,000,000 to 70,000,000 (effective 2025-06-17).

“2) an amendment to the Company’s Certificate of Incorporation (“Amendment No. 2”) to increase the number of authorized shares of Class A Common Stock from 30,000,000 shares to 60,000,000 shares and, accordingly, to increase the number of authorized shares of the Company’s Common Stock from 40,000,000 to 70,000,000”

Bakkt, Inc.: Amendment to provide for officer exculpation as permitted by Delaware law (effective 2025-06-17).

“1) an amendment to the Company’s Certificate of Incorporation (“Amendment No. 1”) to provide for officer exculpation as permitted by Delaware law”

Rivian Automotive, Inc. / DE: Amendment increased authorized Class A common stock from 3,500,000,000 to 5,250,000,000 shares, added officer exculpation provision, and clarified voting standard for amending authorized shares under DGCL Section 242(d)(2) (effective 2025-06-20).

“On June 18, 2025, at Rivian Automotive, Inc.’s (the “Company”) Annual Meeting of Stockholders (the “Annual Meeting”), the Company’s stockholders approved the following amendments to the Company’s Amended and Restated Certificate of Incorporation (collectively, the “Amendments”), each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 29, 2025 (the “Proxy Statement”): • an increase in the number of authorized shares of Class A common stock from 3,500,000,000 to 5,250,000,000 shares, which in turn increased the total number of authorized shares of common stock from 3,507,825,000 to 5,257,825,000; • a provision exculpating certain corporate officers from liability for breach of the fiduciary duty of care in certain circumstances; and • clarifications that the voting standard found in Section 242(d)(2) of the Delaware General Corporation Law would apply to any amendment to increase the number of authorized shares o”

La Rosa Holdings Corp.: Filed Certificate of Designation designating 6,000 shares as Series B Preferred Stock (effective 2025-06-18).

“On June 18, 2025, in connection with the Exchange Agreement, the Board approved, and the Company filed the Certificate of Designation with the Secretary of State of the State of Nevada, designating 6,000 shares of preferred stock of the Company as Series B Preferred Stock.”

Slide Insurance Holdings, Inc.: Amended and restated bylaws became effective in connection with IPO closing (effective 2025-06-20).

“its amended and restated bylaws (the “Bylaws”) became effective, in connection with the closing of the IPO.”

Slide Insurance Holdings, Inc.: Amended and restated certificate of incorporation filed in connection with IPO closing (effective 2025-06-20).

“On June 20, 2025, in connection with the closing of the IPO, the Company filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware”

nCino, Inc.: Approved amendment to declassify the Board of Directors, phasing out classified terms and providing for annual election of directors (effective 2025-06-18).

“the stockholders of nCino, Inc., a Delaware corporation (the “Company”), approved a proposal to amend and restate (the “Amendment”) the Company’s Second Amended and Restated Certificate of Incorporation to phase out the classification of the terms of the Company’s board of directors (the “Board”) and to provide instead for the annual election of directors”

Caris Life Sciences, Inc.: Amended and Restated Bylaws effective upon closing of IPO (effective 2025-06-20).

“On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).”

Caris Life Sciences, Inc.: Amended and Restated Certificate of Formation effective upon closing of IPO (effective 2025-06-20).

“On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).”

TEAM INC: Deleted language specifying conditions for cause in director removal from Article VII, Section 5 of the charter (effective 2025-06-18).

“The Charter Amendment deleted language previously in Article VII, Section 5 of the Company’s Amended and Restated Certificate of Incorporation that specified when cause is deemed to exist in connection with the removal of directors.”

SAGA COMMUNICATIONS INC: Board adopted amended and restated bylaws with changes to shareholder nomination procedures, disclosure requirements, meeting conduct, and other updates (effective 2025-06-19).

“On June 19, 2025, the Board of Directors (the “ Board ”) of Saga Communications, Inc. (the “ Company ”) adopted and approved the Amended and Restated Bylaws of the Company (the “ Amended and Restated Bylaws ”), effective as of June 19, 2025.”

Match Group, Inc.: Amended and restated bylaws to reflect corresponding changes relating to the Fifth Amended and Restated Certificate (effective 2025-06-18).

“Upon the effectiveness of the Fifth Amended and Restated Certificate, on June 18, 2025, the Board amended and restated the bylaws of the Company (as amended, the “Fifth Amended and Restated Bylaws”) to reflect corresponding changes relating to the Fifth Amended and Restated Certificate.”

Match Group, Inc.: Approved amendment and restatement of the certificate of incorporation to declassify the Board over a three-year period and eliminate inoperative provisions (effective 2025-06-18).

“At the 2025 Annual Meeting, the Company’s stockholders approved an amendment and restatement of the Company’s certificate of incorporation (as amended and restated, the “Fifth Amended and Restated Certificate”), which had previously been approved by the Board of Directors of the Company (the “Board”), subject to stockholder approval, to declassify the Board over a three-year period.”

SOLITARIO RESOURCES CORP.: Increased authorized common shares to 200 million via a charter amendment filed and effective June 19, 2025 (effective 2025-06-19).

“Solitario’s shareholders approved an amendment to Solitario’s Articles of Incorporation to increase the authorized number of shares of Solitario common stock to 200 million shares (the “Amendment”). The Amendment was filed with the Colorado Secretary of State on June 19, 2025, and was effective upon filing.”

VOLITIONRX LTD: Increased authorized shares from 175 million to 325 million via amendment to certificate of incorporation (effective 2025-06-18).

“On June 18, 2025, VolitionRx Limited (the " Company ") held its annual meeting of stockholders (the " Annual Meeting "). At the Annual Meeting, the Company’s stockholders approved a Certificate of Second Amendment (the " Amendment ") of the Second Amended and Restated Certificate of Incorporation (the " Restated Certificate "), providing for an increase in authorized shares from one hundred seventy-five million (175,000,000) shares to three hundred twenty-five million (325,000,000) shares, consisting of three hundred twenty-five million (325,000,000) shares of common stock, par value $0.001 per share. The Amendment had previously been approved by the Board of Directors on April 2, 2025, subject to the approval of the Company’s Stockholders. The Amendment became effective upon its filing with the Secretary of State of the State of Delaware on June 18, 2025.”

DOLLAR TREE, INC.: Amended By-Laws Article III, Section 2 to decrease the number of directors from twelve to eleven (effective 2025-06-19).

“On June 19, 2025, Dollar Tree, Inc. (the “Company”) amended the Company’s By-Laws to revise Article III, Section 2 of the By-Laws to decrease the number of directors from twelve (12) to eleven (11).”

STURM RUGER & CO INC: Amended and restated bylaws to increase maximum board size from nine to ten directors (effective 2025-06-19).

“On June 19, 2025, the Board amended and restated the Company’s by-laws (as so amended and restated, the “Amended and Restated By-Laws”), effective as of the same date. The Amended and Restated By-Laws modified the provisions of Article 3, Section 2 of the Company’s by-laws to increase the maximum size of the Board to ten (10) directors.”

TERADYNE, INC: On June 20, 2025, the Board of Directors amended and restated the By-Laws, adjusting director nomination and shareholder proposal notice windows, updating procedural and information requirements for nominations and proposals, clarifying plurality voting standard in contested elections, and clarifyin (effective 2025-06-20).

“In connection with its periodic review of the Amended and Restated By-Laws (the “ By-Laws ”) of Teradyne, Inc. (the “ Company ”), on June 20, 2025, the Board of Directors of the Company amended and restated the By-Laws effective immediately.”

PEGASYSTEMS INC: Increased authorized common stock from 200,000,000 to 400,000,000 shares (effective 2025-06-17).

“On June 17, 2025, the shareholders of the Company approved amendments to the Company’s Restated Articles of Organization (the “Charter” ) to increase the number of authorized shares of the Company’s common stock, $0.01 par value per share, from 200,000,000 shares to 400,000,000 shares.”

Worksport Ltd: Filed Certificate of Designation for 8% Series C Convertible Preferred Stock, designating 3,100,000 shares (effective 2025-06-13).

“On June 13, 2025, in connection with the Offering, the Company filed the Certificate of Designation of the 8% Series C Convertible Preferred Stock with the Secretary of State of the State of Nevada, designating 3,100,000 shares of such series.”

UNITED STATES STEEL CORP: Certificate of incorporation and bylaws amended and restated in connection with merger.

“At the Effective Time, (a) the Company’s certificate of incorporation was amended and restated until thereafter amended in accordance with such certificate and the DGCL and (b) the bylaws of 2023 Sub as in effect immediately prior to the Effective Time, reflecting certain amendments, became the bylaws of the surviving corporation until thereafter amended in accordance with such bylaws, the certificate of incorporation of the surviving corporation and DGCL.”

CRESCENT BIOPHARMA, INC.: Company ceased to be a shell company as a result of the Merger (effective 2025-06-16).

“As a result of the Merger, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) as of the Closing Date.”

CRESCENT BIOPHARMA, INC.: Adopted a new Code of Business Conduct and Ethics superseding the prior code (effective 2025-06-13).

“On June 13, 2025, in connection with the Closing, the Board adopted a new Code of Business Conduct and Ethics of the Company (the “ Code of Conduct ”), effective as of such date. The Code of Conduct supersedes the existing Code of Business Conduct and Ethics, as previously adopted by GlycoMimetics’ board of directors (the “ Existing Code of Conduct ”).”

CRESCENT BIOPHARMA, INC.: Redomestication from Delaware to the Cayman Islands, including adoption of Cayman Islands Memorandum and Articles of Association (effective 2025-06-16).

“Pursuant to the Plan of Conversion, to effect the Redomestication, the Company (i) filed a Certificate of Conversion with the Secretary of State of the State of Delaware (the “ Certificate of Conversion ”), with an effective time of 4:45 p.m., Eastern Daylight Time, on June 16, 2025, and (ii) filed the Cayman Articles, among other things, with the Cayman Islands Registrar of Companies, effective on June 16, 2025.”

CRESCENT BIOPHARMA, INC.: Filed Certificate of Amendment to change company name (effective 2025-06-13).

“To effect the Company Name Change, GlycoMimetics filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “ Name Change Certificate of Amendment ”), with an effective time of 8:50 a.m., Eastern Daylight Time, on June 13, 2025.”

CRESCENT BIOPHARMA, INC.: Filed Certificate of Amendment to increase authorized shares to 175,000,000 (effective 2025-06-13).

“To effect the Authorized Share Increase, GlycoMimetics filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “ Authorized Share Increase Certificate of Amendment ”), with an effective time of 8:47 a.m., Eastern Daylight Time, on June 13, 2025.”

CRESCENT BIOPHARMA, INC.: GlycoMimetics stockholders approved amendments to the certificate of incorporation to increase authorized shares from 150,000,000 to 175,000,000, effect a 1-for-100 reverse stock split, and redomesticate from Delaware to the Cayman Islands (effective 2025-06-13).

“GlycoMimetics’ stockholders approved, among other matters, amendments to the amended and restated certificate of incorporation of GlycoMimetics to (i) increase the number of authorized shares of Company common stock from 150,000,000 shares to 175,000,000 (the “ Authorized Share Increase ”), (ii) effect the Reverse Stock Split and (iii) effect the redomestication of GlycoMimetics from the State of Delaware to the Cayman Islands by conversion and by way of continuation (the “ Redomestication ”) by means of a plan of conversion (the “ Plan of Conversion ”), in each case as described in the Proxy Statement/Prospectus.”

Cocrystal Pharma, Inc.: Amended the quorum requirement to one third of the voting power of outstanding shares of all classes or series of voting stock (effective 2025-06-17).

“On June 17, 2025, the Board of Directors of Cocrystal Pharma, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws to the quorum requirement to provide that one third of the aggregate voting power of the outstanding shares of all classes or series of voting stock then entitled to vote, represented in person or by proxy, shall constitute a quorum at a meeting of stockholders (the “Amendment”).”

Synergy CHC Corp.: Amendment to Articles of Incorporation to authorize issuance of up to 1,000,000 shares of Preferred Stock.

“At the Annual Meeting the Company’s stockholders approved an amendment (the “Certificate of Amendment”) to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), to authorize the issuance of up to 1,000,000 shares of preferred stock, par value $0.00001 per share (“Preferred Stock”).”

Udemy, Inc.: Amendment to certificate of incorporation to limit liability of certain officers (effective 2025-06-16).

“At the Annual Meeting, the Company’s stockholders approved the amendment of the Company’s amended and restated certificate of incorporation to limit the liability of certain officers of the Company as permitted by Delaware law. A certificate of amendment to the amended and restated certificate of incorporation was filed with the office of the Secretary of State of the State of Delaware on June 16, 2025, and is effective as of that date.”

C4 Therapeutics, Inc.: Stockholders approved an amendment to the Fifth Amended and Restated Certificate of Incorporation to increase authorized common shares from 150,000,000 to 300,000,000, which was filed and became effective on June 18, 2025 (effective 2025-06-18).

“On June 18, 2025 , the Company filed a Certificate of Amendment to the Company’s Fifth Amended and Restated Certificate of Incorporation (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware and the Certificate of Amendment became effective on filing.”

WinVest Acquisition Corp.: Approved an amendment to the amended and restated certificate of incorporation to extend the Termination Date from June 17, 2025 to the Charter Extension Date, and to allow for up to two additional monthly extensions by board resolution upon sponsor request until September 17, 2025 (effective 2025-06-17).

“At the Extension Meeting, the Company’s stockholders approved an amendment to the Company’s amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation,” and such amendment, the “Extension Amendment”), to extend the Termination Date from June 17, 2025 (the “Current Termination Date”) to the Charter Extension Date, and to allow the Company, without another stockholder vote, to elect to extend the Termination Date on a monthly basis for up to two times by an additional one month (or such shorter period as may be requested by the Sponsor) each time (each, an “Extension”) after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until September 17, 2025, or a total of up to three months after the Current Termination Date, unless the closing of the Company’s Business Combination shall have occurred prior thereto (the “Exten”

SBC Medical Group Holdings Inc: Adoption of amended and restated charter to declassify the board of directors, ending director terms at the 2026 annual meeting and requiring annual election of all director nominees thereafter (effective 2025-06-13).

“As described under Item 5.07 of this Current Report on Form 8-K (the “Report”), SBC Medical Group Holdings Incorporated (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on June 13, 2025. At the Annual Meeting, upon the recommendation of the Company’s board of directors, the Company’s stockholders approved an the adoption of an amendment and restatement of the Company’s certificate of incorporation (the “Amended and Restated Charter”), which will declassify the board of directors such that the terms of all the Company’s current directors will end at the 2026 annual meeting of stockholders, and all director nominees will stand for election annually at and after the 2026 annual meeting of stockholders.”

Forward Industries, Inc.: Amended quorum requirement for shareholders meetings from majority to 33.3% of outstanding shares entitled to vote (effective 2025-06-16).

“On June 16, 2025, the Board of Directors of Forward Industries, Inc. (the “Company”) approved an amendment to the Company’s Third Amended and Restated Bylaws (the “Bylaws”) and adopted an amendment to the quorum requirement contained in Article II, Section 205 of the Bylaws (the “Amendment”) to provide that the holders of thirty-three and one third percent (33.3%) of the outstanding shares of stock of the Company entitled to vote at a shareholders meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business .”

QUANTUM CORP /DE/: Reduced quorum requirement for stockholder meetings to one-third of outstanding capital stock (effective 2025-06-12).

“On June 12, 2025, the Board approved an amendment to the Company’s Amended and Restated Bylaws to reduce the quorum requirement for transacting business at meetings of stockholders to one-third of the capital stock issued and outstanding and entitled to vote.”